Keyword: Auris Surgical Robotics
The data are from the system's first study in live human subjects since its clearance and launch last year. Two previous studies operated on cadavers.
Sanofi's CMO takes on chief digital officer role; Parexel nabs four high-profile FDA staffers; and Nimbus poaches Janssen's discovery head as CSO.
Johnson & Johnson is diving deeper into robotic surgery with a $3.4 billion deal for Auris Health, designer of endoscopes aimed at lung cancer.
Johnson & Johnson is eyeing robotic surgery maven Auris Health and plans to purchase it at above its $2 billion valuation, according to reports.
Robotic surgery platform developer Auris Health has raked in another $220 million in equity financing, bringing its total to more than $700 million.
The nod clears the Intuitive Surgical founder’s latest venture to sell the device for use in bronchoscopic procedures in lung cancer patients.
With a rare new entrant, the minimally invasive robotic surgery arena may be ripe for a shake-up in 2018.
Intuitive Surgical is dipping a toe into diagnostics—a new study showed its flexible robotics platform was used safely to take lung tissue samples.
Mazor Robotics earned an FDA nod for its software that helps surgeons plan spinal deformity corrections and spinal alignment procedures.
Since its founding, Auris has operated in stealth mode, disclosing virtually nothing and billing itself only as “a company based in Silicon Valley.”